Vietnam’s Mekong Capital has exited its 25% stake in domestic pharmaceuticals company Traphaco for about $64.5 million. It represents a gross return multiple of 6.3x for the investment.
Mekong invested Traphaco via its Vietnam Azalea Fund (VAF), initially taking a 5% stake in 2007 and becoming the company’s first foreign shareholder. VAF subsequently increased its stake through several...
California Public Employees’ Retirement System's (CalPERS) decision to launch a private equity direct investment strategy sets it apart from its counterparts, but the plan will need conviction and focus to succeed
Vision Plus Capital looks to tap the entrepreneurial talent developing in Alibaba Group's ecosystem for its second US dollar and renminbi-denominated funds
Advantage Partners aims to build on the firm's experience connecting Asian entrepreneurs with opportunities in Japan in its first Asia-focused fund
Ally Bridge Group, Hillhouse Capital and 6 Dimensions Capital have co-led a $300 million Series C round for Grail, a biotechnology development firm based in Hong Kong and the US.